DVA Earnings Date: Feb 1, 2027 (Estimated) — DaVita Inc.
NYSE · Healthcare · Medical Care Facilities
Updated
When is DVA's next earnings date?
DaVita Inc. (DVA) is expected to report Q4 2026 earnings on Monday, February 1, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $4.44 on revenue of $3.63B.
How did DVA do in its last earnings report?
In its most recent report on Oct 29, 2026 (Q3 2026), DaVita Inc. posted EPS of $3.82 versus the $3.57 estimate, a beat of 7.0%. Revenue was $3.58B against a $3.52B estimate.
How much does DVA stock move after earnings?
DVA beat EPS estimates in 6 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 12.6% (up or down) in the day after earnings.
About DaVita Inc.
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
🤖 AI Earnings Analysis
DaVita delivered a strong dialysis-sector quarter, with revenue of $3.6B and EPS of $3.82 beating estimates; EPS rose from $2.51 year over year. The $14.10–$15.20 EPS outlook frames the next test.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | Q3 2026 | 3.57 | 3.82 | +7.00% | $3.58B | ✅ Beat | — | — | — |
| 2026-08-04 | Q2 2026 | 3.88 | 4.02 | +3.61% | $3.55B | ✅ Beat | -17.24% | -21.78% | -21.32% |
| 2026-05-05 | Q1 2026 | 2.35 | 2.87 | +22.13% | $3.42B | ✅ Beat | +23.46% | +27.70% | +22.37% |
| 2026-02-02 | Q4 2025 | 3.21 | 3.40 | +5.92% | $3.62B | ✅ Beat | +21.17% | +23.79% | +39.21% |
| 2025-10-29 | Q3 2025 | 3.22 | 2.51 | -22.05% | $3.42B | ❌ Miss | -6.17% | -4.27% | -5.44% |
| 2025-08-05 | Q2 2025 | 2.73 | 2.95 | +8.06% | $3.38B | ✅ Beat | -9.04% | -6.01% | -3.53% |
| 2025-05-12 | Q1 2025 | 2.02 | 2.00 | -0.99% | $3.22B | ❌ Miss | -0.31% | +0.37% | -4.33% |
| 2025-02-13 | Q4 2024 | 2.14 | 2.24 | +4.67% | $3.29B | ✅ Beat | -11.09% | -19.58% | -15.71% |
Showing last 8 quarters.